4 min read Weight loss might be what gets the headlines, but for many people on GLP-1 medications like Ozempic, Wegovy, or Mounjaro, the most profound change isnt on the scale
A narrative review was conducted based on a literature search for randomised controlled trials, cohort studies, case reports, and systematic reviews reporting outcomes of GLP-1 RAs therapies in SIH and SID
Before starting pharmacotherapy, healthcare professionals should assess for secondary causes of obesity and exclude active eating disorders
Imaging Sci Dent
The combination of slower digestibility and increased fibre content supports blood glucose management while promoting satiety
As our understanding of HFpEF evolves, GLP-1RAs have the potential to become a cornerstone of therapy, addressing the multifactorial nature of this condition and improving outcomes in a challenging patient population